BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16506220)

  • 61. On the excess of G --> T transversions in the p53 gene in lung cancer cell lines. Reply to Pfeifer and Hainaut.
    Rodin SN; Rodin AS
    Mutat Res; 2004 Jan; 545(1-2):141-4; author reply 145-6; discussion 147. PubMed ID: 14698424
    [TBL] [Abstract][Full Text] [Related]  

  • 62. p53 mutations in lung cancers from non-smoking atomic-bomb survivors.
    Takeshima Y; Seyama T; Bennett WP; Akiyama M; Tokuoka S; Inai K; Mabuchi K; Land CE; Harris CC
    Lancet; 1993 Dec 18-25; 342(8886-8887):1520-1. PubMed ID: 7902903
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Smoking, lung cancers and their TP53 mutations.
    Cooper CS
    Mutagenesis; 2002 Jul; 17(4):279-80. PubMed ID: 12110621
    [No Abstract]   [Full Text] [Related]  

  • 64. Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer.
    Zalcman G; Trédaniel J; Hirsch A; Lubin R; Soussi T
    Chest; 1994 Oct; 106(4):1309-10. PubMed ID: 7924532
    [No Abstract]   [Full Text] [Related]  

  • 65. On the origin of G --> T transversions in lung cancer.
    Pfeifer GP; Hainaut P
    Mutat Res; 2003 May; 526(1-2):39-43. PubMed ID: 12714181
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis.
    Benner SE; Lippman SM; Wargovich MJ; Velasco M; Peters EJ; Morice RC; Hong WK
    Int J Cancer; 1992 Aug; 52(1):44-7. PubMed ID: 1500226
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multifocal lung cancers--clonality vs field cancerization and does it matter?
    Gazdar AF; Minna JD
    J Natl Cancer Inst; 2009 Apr; 101(8):541-3. PubMed ID: 19351914
    [No Abstract]   [Full Text] [Related]  

  • 68. The TP53 gene, tobacco exposure, and lung cancer.
    Toyooka S; Tsuda T; Gazdar AF
    Hum Mutat; 2003 Mar; 21(3):229-39. PubMed ID: 12619108
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra.
    Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Nakagawa K; Hayashi J; Tsuchiya E
    Am J Pathol; 2000 Dec; 157(6):2133-41. PubMed ID: 11106585
    [TBL] [Abstract][Full Text] [Related]  

  • 71. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
    Olshan AF; Weissler MC; Pei H; Conway K
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
    [TBL] [Abstract][Full Text] [Related]  

  • 72. p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity.
    Ostwald C; Gogacz P; Hillmann T; Schweder J; Gundlach K; Kundt G; Barten M
    Int J Cancer; 2000 Oct; 88(1):82-6. PubMed ID: 10962443
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Etiologic value of p53 mutation spectra and differences with histology in lung cancers.
    Shimmyo T; Okada A; Hashimoto T; Kobayashi Y; Miyagi Y; Ishikawa Y; Nakagawa K; Osada H; Tsuchiya E
    Cancer Sci; 2008 Feb; 99(2):287-95. PubMed ID: 18271927
    [TBL] [Abstract][Full Text] [Related]  

  • 75. p53 mutation spectra for squamous cell carcinomas at different levels of human bronchial branches.
    Shimmyo T; Hashimoto T; Kobayashi Y; Miyagi Y; Ishikawa Y; Nakagawa K; Osada H; Tsuchiya E
    Int J Cancer; 2006 Aug; 119(3):501-7. PubMed ID: 16506220
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.